Clinical Trials

We are currently enrolling participants in one Phase 2/3 national clinical trial for women with pattern hair loss, and one Phase 3 national clinical trial for men with pattern hair loss, to evaluate our lead product candidate, VDPHL01, the potential first-ever extended release oral minoxidil for hair growth.

For more information and to find a study site, visit www.phlstudy.com or www.phlstudy.com/female